Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
JIA Zhi-Fan, WANG Wei-Li, WONG Fu-Hai. Effect of ciprofloxacin on pharmacokinetics and pharmacodynamics of glipizide[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(3): 238-240.
1 张菁,张婴元,郁继诚,等.三种氟诺酮类抗菌药的药物动力学研究.中国抗生素杂志,1993;18(5):334 2 Rayner CF,Tillotson G,Cole PJ,e t al. Efficacy and safty of long-term ciprofloxacin in the management of brochiectasis. J Antimicrob Chem other,1994;34(1):149 3 翁心华. 糖尿病与感染.上海医学,1990;13(12):701 4 莫惠平. 氟喹诺酮类药物动力学与临床应用的关系.中国医院药学杂志,1998;18(2):57 5 周序开.血浆(及全血) 葡萄糖测定-葡萄糖氧化酶法的探讨.中华医学检验杂志,1982;5(1):56 6 王吉甫. 药物性大白鼠糖尿病模型.中华实验外科杂志,1986;3(3):127 7 Kivisto K T,Neuvonen P J. Enchancement of absorption and effect of glipizide by magnesium hydroxide. Clin Pharmacol Ther,1991;49(1):39 8 王贤才,译,王能熙,校.氟喹喏酮类.临床药物大典.青岛出版社,1994:1235 9 Wijnands WJA,Vree T B,Van Herwaarden CLA. The influence of quinolone derivatives on the theophylline clearance. Br J Clin Pharmocol,1986;22:67
YANG Jing-jing, SUN Hua, ZHAO Jun, DAI Min, LI Xiang-hong, ZHAO Ya-nan, LU Jian-ping, XIE Hai-tang.
Determination of Pidotimod in Human Serum by HPLC-MS/MS
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 308-312.